At a glance
Debiopharm Innovation Fund’s objective is to make strategic investments in innovative companies with technologies and business models that change the way we develop drugs and treat patients.
We bring value to our portfolio companies through our knowledge in medicine, pharmaceutical development, regulatory/reimbursement aspects, management and expertise in bringing products to market. We drive our portfolio investments to successful exits.
Make new investments in companies developing innovative therapeutics, diagnostics, and smart data solutions with a spirit of partnership. Our goals are:
- Long term value creation
- Minority participation
- Advising and helping with technical and business operations
- Active in the Board of Directors
Our investment criteria
- Experienced management team
- Innovative technology
- Fit with Debiopharm Group’s interests
- Strong execution plan
Our achievements (as Debiopharm Diagnostics)
- Over USD 95 million invested since 2008
- Cumulative equity raised by all companies: USD 500 million
- Debiopharm Diagnostics led 10 out of the 14 last investment rounds
- Progress to date: 4 companies with commercial products, one M&A and one IPO.